CATALOGO DEI PRODOTTI DELLA RICERCA

PIZZOLO, Francesca
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 10.146
EU - Europa 9.292
AS - Asia 5.998
SA - Sud America 749
AF - Africa 133
OC - Oceania 19
Continente sconosciuto - Info sul continente non disponibili 8
Totale 26.345
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 10.002
RU - Federazione Russa 3.408
SG - Singapore 2.483
GB - Regno Unito 2.000
CN - Cina 1.744
DE - Germania 917
IT - Italia 645
BR - Brasile 611
SE - Svezia 580
VN - Vietnam 579
FI - Finlandia 462
FR - Francia 454
HK - Hong Kong 450
IE - Irlanda 394
KR - Corea 206
UA - Ucraina 119
CA - Canada 89
JP - Giappone 87
IN - India 78
TR - Turchia 77
NL - Olanda 66
BE - Belgio 59
AR - Argentina 54
BD - Bangladesh 46
PL - Polonia 43
ZA - Sudafrica 40
ID - Indonesia 34
MX - Messico 33
ES - Italia 29
NG - Nigeria 27
IQ - Iraq 25
AT - Austria 23
CO - Colombia 20
PK - Pakistan 20
UZ - Uzbekistan 18
IR - Iran 17
AU - Australia 16
IL - Israele 15
SA - Arabia Saudita 15
VE - Venezuela 15
CZ - Repubblica Ceca 14
CL - Cile 13
JO - Giordania 13
AZ - Azerbaigian 12
EC - Ecuador 12
EG - Egitto 12
MA - Marocco 11
AE - Emirati Arabi Uniti 10
TN - Tunisia 10
NP - Nepal 9
HR - Croazia 8
LT - Lituania 8
MY - Malesia 8
PY - Paraguay 8
AL - Albania 7
LB - Libano 7
PE - Perù 7
PH - Filippine 7
RO - Romania 7
DZ - Algeria 6
EU - Europa 6
KE - Kenya 6
UY - Uruguay 6
JM - Giamaica 5
LV - Lettonia 5
PS - Palestinian Territory 5
PT - Portogallo 5
TH - Thailandia 5
CH - Svizzera 4
ET - Etiopia 4
GR - Grecia 4
KG - Kirghizistan 4
KZ - Kazakistan 4
BG - Bulgaria 3
BJ - Benin 3
BN - Brunei Darussalam 3
BY - Bielorussia 3
CR - Costa Rica 3
DK - Danimarca 3
EE - Estonia 3
HN - Honduras 3
LU - Lussemburgo 3
MT - Malta 3
NZ - Nuova Zelanda 3
SN - Senegal 3
TG - Togo 3
AF - Afghanistan, Repubblica islamica di 2
BH - Bahrain 2
BO - Bolivia 2
DO - Repubblica Dominicana 2
HU - Ungheria 2
ME - Montenegro 2
NI - Nicaragua 2
OM - Oman 2
PA - Panama 2
QA - Qatar 2
SI - Slovenia 2
TT - Trinidad e Tobago 2
XK - ???statistics.table.value.countryCode.XK??? 2
AM - Armenia 1
Totale 26.318
Salva come PNG Salva come JPEG
Città #
Southend 1.627
Singapore 1.402
Moscow 1.162
Chandler 1.050
Ashburn 1.041
Jacksonville 1.029
Dallas 997
San Jose 834
Woodbridge 658
Ann Arbor 549
Hong Kong 442
Dublin 392
Verona 350
Houston 297
The Dalles 286
New York 283
Beijing 252
Ho Chi Minh City 170
Wilmington 170
Los Angeles 160
Lawrence 156
Princeton 156
Munich 138
Helsinki 134
Hanoi 132
Jinan 122
Nanjing 116
Boardman 109
Tokyo 86
Shenyang 77
Buffalo 74
Tianjin 74
Lancaster 72
São Paulo 70
Turku 67
Santa Clara 66
Hebei 60
Nürnberg 60
Brussels 59
Council Bluffs 58
Columbus 57
Redondo Beach 57
Sindelfingen 56
Dong Ket 54
Milan 52
Orem 52
Zhengzhou 50
Nanchang 43
Seoul 43
London 42
Guangzhou 40
Changsha 39
Montreal 39
Denver 38
Redmond 38
Haikou 35
Hangzhou 34
Warsaw 34
Seattle 33
Stockholm 33
Ningbo 32
Jiaxing 29
Toronto 29
Washington 29
Frankfurt am Main 28
Chennai 26
Johannesburg 26
Phoenix 26
Abuja 25
Amsterdam 25
Boston 25
Chicago 25
Taiyuan 25
Haiphong 24
Taizhou 24
Poplar 23
Da Nang 22
Falkenstein 22
Atlanta 21
Brooklyn 21
Rio de Janeiro 21
Shanghai 20
Padova 19
San Francisco 19
Manchester 18
Ankara 17
Norwalk 17
Tashkent 17
Jakarta 16
Mestre 16
Vienna 16
Düsseldorf 14
Fuzhou 14
Kent 14
Redwood City 14
Dhaka 13
Lanzhou 13
Rome 13
Boydton 12
Campinas 12
Totale 16.728
Salva come PNG Salva come JPEG
Nome #
Multimodality Imaging in Aldosterone-Induced Cardiomyopathy: Early Detection and Prognostic Implications 382
Increased urinary excretion of the epithelial Na channel activator prostasin in patients with primary aldosteronism 314
Apparent Mineralocorticoid Excess by a Novel Mutation and Epigenetic Modulation by HSD11B2 Promoter Methylation 313
Altered renal folate handling in hypertensive patients with nephroangiosclerotic damage 297
A relative ADAMTS13 deficiency supports the presence of a secondary microangiopathy in COVID 19 259
Abnormal gel flotation caused by contrast media during adrenal vein sampling 253
High plasma apolipoprotein C-III levels predict total and cardiovascular mortality in patients with angiographically defined coronary artery disease. 248
High plasma apolipoprotein C-III levels predict total and cardiovascular mortality in patients with angiographically defined coronary artery disease. 244
Global DNA hypomethylation in peripheral blood mononuclear cells as a biomarker of cancer risk 239
ALOX5AP gene variants and risk of coronary artery disease: an angiography-based study 235
Promoter methylation in coagulation F7 gene influences plasma FVII concentrations and relates to coronary artery disease. 224
Urinary protease inhibitor Serpin B3 is higher in women and is further increased in female patients affected by aldosterone producing adenoma 223
Assessment of SARS-CoV-2 IgG and IgM antibody detection with a lateral flow immunoassay test 220
Global DNA hypomethylation in peripheral blood mononuclear cells as a biomarker of cancer risk 218
Novel serum paraoxonase activity assays are associated with coronary artery disease 217
Urinary prostasin in normotensive individuals: correlation with the aldosterone to renin ratio and urinary sodium. 216
Baricitinib restrains the immune dysregulation in patients with severe COVID-19 213
Renovascular disease: effect of ACE gene deletion polymorphism and endovascular revascularization. 201
Additive effect of LRP8/APOER2 R952Q variant to APOE epsilon2/epsilon3/epsilon4 genotype in modulating apolipoprotein E concentration and the risk of myocardial infarction: a case-control study. 200
Combined effect of hemostatic gene polymorphisms and the risk of myocardial infarction in patients with advanced coronary atherosclerosis. 199
Deep vein thrombosis in SARS-CoV-2 pneumonia-affected patients within standard care units: Exploring a submerged portion of the iceberg 198
ApoC-III gene polymorphisms and risk of coronary artery disease 196
Acquired and genetic determinants of homocysteine in atheromatous renel artery stenosis with mild renal insufficiency 196
Association of endogenous thrombin potential (ETP) with coronary artery disease. An angiography-based study 195
Genetic risk score from GWA studies is strongly associated with angiographically-defined coronary artery disease, but not with mortalilty in the setting of secondary prevention. 193
miRNAs purification and analysis from urinary exosomes. 193
Aldosterone to renin ratio in a primary care setting:the Bussolengo study. 190
Association of endogenous thrombin potential (ETP) with coronary artery disease. an angiography-based study. 188
The -1131 T > C and S19W APOA5 gene polymorphisms are associated with high levels of triglycerides and apolipoprotein C-III, but not with coronary artery disease: an angiographic study 185
Elevated D-dimer levels are associated with coronary artery disease and cardiovascular death in an angiographically-studied population 184
PON2 Ser311Cys polymorphism is a predictor of total and cardiovascular mortality in patients with angiographically proven coronary artery disease. 184
Hyperhomocysteinemia and Mortality after Coronary Artery Bypass Grafting 183
Association of endogenous thrombin potential (ETP) with coronary artery disease. An angiography-based study. 183
High ferritin and low folate increases PBMCs genomic DNA methylation in association with SHMT1-1420TT variant. 182
Acute haemolysis by cold antibody during SARS-CoV-2 infection in a patient with Evans syndrome: a case report and literature review 181
Apolipoprotein C-III, n-3 Polyunsaturated Fatty Acids, and “Insulin-Resistant” T-455C APOC3 gene polymorphism in heart disease patients: example of gene-diet interaction 180
Hyperhomocysteinemia and mortality after coronary artery by-pass grafing. 180
Increased Incidence of Ischemic Cerebrovascular Events in Cardiovascular Patients With Elevated Apolipoprotein CIII 180
Vitamins and epigenetics 178
Hyperhomocysteinemia in relation to total and cardiovascular death after coronary bypass grafting. 177
Homozygosity for APOCIII variant at position 455 of insulin responsive element promoter region is associated with increased APOC-III levels and risk of coronary artery disease 176
Low circulating vitamin B6 markers of inflammation, and risk of coronary artery disease. 176
PON2 Ser311Cys polymorphism is a predictor of total and cardiovascular mortality in patients with angiographically confirmed coronary artery disease. 176
Apolipoprotein C-III predicts cardiovascular mortality in severe coronary artery disease and is associated with an enhanced plasma thrombin generation 175
NT-proBNP, a useful tool in hypertensive patients undergoing a diagnostic evaluation for primary aldosteronism. 174
Epigenetics regulation of HSD11B2 gene by promoter methylation in glucocorticoid-treated patients 174
Interaction between metabolic syndrome and PON 1 polymorphism as a determinant of the risk of coronary artery disease 173
Effects Of Female Sex Hormones And Contraceptive Pill On The Diagnostic Work-Up For Primary Aldosteronism 173
Female urinary proteomics: New insight into exogenous and physiological hormone-dependent changes. 172
Antihypertensive efficacy of spironolactone: what about sex? 171
Serum uric acid, but not rs7442295 polymorphism of SCL2A9 gene, predicts total and cardiovascular mortality in severe coronary artery disease. 171
Basophil Blood Cell Count Is Associated With Enhanced Factor II Plasma Coagulant Activity and Increased Risk of Mortality in Patients With Stable Coronary Artery Disease: Not Only Neutrophils as Prognostic Marker in Ischemic Heart Disease 171
Interaction between folate and MTHFR1298 A/C polymorphism on Genomic DNA Methylation 170
Aldosterone to renin ratio in a primary care setting: the Bussolengo study 170
High Plasma Levels of Activated Factor VII-Antithrombin Complex Point to Increased Tissue Factor Expression in Patients with SARS-CoV-2 Pneumonia: A Potential Link with COVID-19 Prothrombotic Diathesis 169
Fully automated chemiluminescence vs RIA aldosterone assay in primary aldosteronism work-up 169
Low plasma vitamin B-6 concentrations and modulation of coronary artery disease risk. 168
Low vitamin B6, markers of inflammation, and risk of coronary artery disease. 168
Interaction between PON 2 polymorphism Ser-Cys and smoking as a determinant of myocardial infarction risk 166
Factor VIII:c Levels in Subjects with the Factor V R2 Polymorphism. 166
PON2 Ser311Cys polymorphism is a predictor of total and cardiovascular mortality in patients with angiographically confirmed coronary artery disease. 166
Elevated D-dimer levels are associated with coronary artery disease and cardiovascular death in an angiographically-studied population. 166
Determinants of serum ferritin and prevalence of iron overload in the Metabolic (Insulin Resistance). 165
Case Report: Microangiopathic Hemolytic Anemia With Normal ADAMTS13 Activity 165
Detection of urinary exosomal HSD11B2 mRNA expression: a useful novel tool for the diagnostic approach of dysfunctional 11β-HSD2-related hypertension 165
Interaction between smoking and PON2 Ser311 Cys polymorphism as a determinant of the risk of myocardial infarction 164
Determinants of serum ferritin in the metabolic syndrome. 164
High levels of homocysteine are associated with small number of traditional cardiovascular risk factors in patients with similar degree of coronary atherosclerosis. 164
Polymorphisms in the Hemostatic Pathway Genes and the Risk of Myocardial infarction in Patients with Advanced Coronary Artery Disease. Results from the Verona Heart Project. 164
Serum uric acid, but not rs7442295 polymorphism of SCL2A9 gene, predicts total and cardiovascular mortality in advanced coronary artery disease. 163
Not Just Arterial Damage: Increased Incidence of Venous Thromboembolic Events in Cardiovascular Patients With Elevated Plasma Levels of Apolipoprotein CIII 163
The RFC1 80G>A, among Common One-Carbon Polymorphisms, Relates to Survival Rate According to DNA Global Methylation in Primary Liver Cancers 162
Impaired activity of 11--hydroxysteroid dehydrogenase type 2 in glucocorticoid treated and in hypertensive patients from primary and tertiary care. 161
Epigenetic control of 11-beta-hydroxysteroid dehydrogenase 2 gene promoter is related to human hypertension 161
Apolipoprotein C-III, metabolic syndrome, and risk of coronary artery disease 160
Prevalence of body iron excess in the metabolic syndrome. 160
ApoE epsilon 2/epsilon 3/epsilon 4 polymorphism, ApoC-III/ApoE ratio and metabolic syndrome 159
Reduced genomic DNA methylation in peripheral mononuclear cells as an index for the occurrence of cancer disease 159
Delation variant of ACE gene is associated with atherosclerotic renal stenosis not with coronary artery disease 158
Genetic and environmental determinants of hyperhomocysteinemia in subjects with angiographically proven coronary artery disease 158
A late diagnosis of Primary Aldosteronism 158
Homocysteine and atheromatous renal artery stenosis 157
Genetic and eviromental determinants of hyperhomocysteinemia in subjects with corocary artery disease 157
Effects of female sex hormones and contraceptive pill on the diagnostic work-up for primary aldosteronism. 157
Serum Uric Acid Levels, but Not rs7442295 Polymorphism of SCL2A9 Gene, Predict Mortality in Clinically Stable Coronary Artery Disease 155
Carriership of apolipoprotein CIII –455C gene variant strongly increases the coronary artery disease risk associated with the metabolic sindrome. 153
Trace Elements Status and Metallothioneins DNA Methylation Influence Human Hepatocellular Carcinoma Survival Rate 153
Primary aldosteronism is a frequent cause of poor blood pressure control despite techically successful endovascular treatment of renal artery stenosis 152
Apolipoprotein CIII,metabolic syndrome,and risk of coronary artery disease. 152
La diagnostica di laboratorio nella sindrome da apparente eccesso di mineralcorticoidi [The laboratory diagnosis of apparent mineralocorticoid excess (AME)] 152
CYSTATIN C VERSUS CREATININE IN RENOVASCULAR DISEASE. 151
Delation variant of ACE gene is associated wwith atherosclerotic renal artery stenosis not with coronary artery disease 151
Factor VII polymorphisms and the risk of myocardial infarction in coronary atherosclerosis. 150
Urinary prostasin: a candidate marker of ENaC activation in humans:study of preliminary feasibility 149
An integrated genomic-transcriptomic approach supports a role for the proto-oncogene BCL3 in atherosclerosis. 148
Primary hyperaldosteronism: a frequent cause of residual hypertension after successful endovascular treatment of renal artery disease 147
Folic acid effects on s-adenosylmethionine, s-adenosylhomocysteine, and DNA methylation in patients with intermediate hyperhomocysteinemia. 147
Sialylated isoforms of apolipoprotein C-III and plasma lipids in subjects with coronary artery disease 147
Epigenetic regulation of coagulation factor VII gene promoter in relationship with 5’F7 polymorphism modulate factor VII levels and myocardial infarction risk 147
Epigenetic control of hydroxysteroid (11-beta) dehydrogenase 2 gene is related to human hypertension 146
Totale 18.345
Salva come PNG Salva come JPEG
Categoria #
all - tutte 79.762
article - articoli 49.472
book - libri 0
conference - conferenze 28.969
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.321
Totale 159.524
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021250 0 0 0 0 0 0 0 0 0 24 147 79
2021/20221.168 70 300 15 117 64 41 15 60 54 38 112 282
2022/20232.922 197 315 250 504 295 659 23 206 352 17 66 38
2023/20241.601 62 101 122 137 170 354 46 116 21 57 230 185
2024/20253.452 187 228 130 599 130 121 211 106 506 226 312 696
2025/202610.762 721 561 1.042 1.844 2.958 773 974 503 806 580 0 0
Totale 26.493